Paradigm Biopharmaceuticals Ltd.ASX: PAR

Ind questions received from US FDA

May 25, 2021 at 2:44 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment